🌟 Hepanib® 200 mg (Sorafenib) Tablets
By Everest Pharma | 28 Tablets Pack
💥 Smart Therapy for Liver, Kidney & Thyroid Cancer
Hepanib® 200 mg is an advanced oral cancer therapy containing Sorafenib, a proven multi-kinase inhibitor that slows tumor growth and blocks cancer cell spread. Designed for patients battling hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and differentiated thyroid carcinoma, Hepanib offers renewed hope and effective treatment in a convenient tablet.
🔬 How It Works
Hepanib works by targeting multiple pathways that cancer cells use to grow and spread. It cuts off the blood supply tumors need, stops cancer cells from multiplying, and reduces tumor progression — giving patients a powerful defense against some of the toughest cancers.
💊 Product Highlights
✅ Strength: 200 mg per tablet
✅ Pack size: 28 film-coated tablets
✅ Active ingredient: Sorafenib
✅ Manufacturer: Everest Pharmaceuticals Ltd.
✅ Oral administration — no hospital infusions
🎯 Approved Indications
✔ Advanced hepatocellular carcinoma (liver cancer)
✔ Advanced renal cell carcinoma (kidney cancer)
✔ Differentiated thyroid carcinoma (unresponsive to radioactive iodine)
⚡ Key Benefits
✔ Multi-targeted action for maximum impact
✔ Convenient once- or twice-daily oral dosing
✔ Suitable with or without food
✔ Manufactured to the highest global standards
✔ Backed by clinical research and trusted worldwide
⚠️ Safety & Monitoring
Common side effects: fatigue, diarrhea, skin reactions, hypertension, hand-foot skin reactions, weight loss
Serious but rare: heart events, severe bleeding, liver impairment
Regular monitoring of blood pressure, liver function, and skin health is advised during treatment.
💾 Storage Instructions
🌐 For More Information
📞 +8801844288466
📧 npmolecule23@gmail.com
🌍 www.npmoleculeoncology.com
📍 Sector-14, Uttara, Dhaka-1230
✨ Hepanib® — Powering Progress in Cancer Treatment
With Hepanib, Everest Pharma delivers cutting-edge innovation and renewed hope to patients fighting advanced cancers.